Swedish Orphan Valuation

SOBI Stock  SEK 267.20  5.00  1.84%   
At this time, the company appears to be overvalued. Swedish Orphan Biovitrum has a current Real Value of kr226.59 per share. The regular price of the company is kr267.2. Our model measures the value of Swedish Orphan Biovitrum from inspecting the company fundamentals such as Operating Margin of 0.24 %, return on equity of 0.11, and Shares Outstanding of 295.99 M as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend acquiring undervalued stocks and selling overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Overvalued
Today
267.20
Please note that Swedish Orphan's price fluctuation is very steady at this time. Calculation of the real value of Swedish Orphan Biovitrum is based on 3 months time horizon. Increasing Swedish Orphan's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Swedish Orphan Biovitrum is useful when determining the fair value of the Swedish stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Swedish Orphan. Since Swedish Orphan is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Swedish Stock. However, Swedish Orphan's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  267.2 Real  226.59 Hype  267.2
The real value of Swedish Stock, also known as its intrinsic value, is the underlying worth of Swedish Orphan Biovitrum Company, which is reflected in its stock price. It is based on Swedish Orphan's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Swedish Orphan's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Swedish Orphan's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
224.76
Downside
226.59
Real Value
293.92
Upside
Estimating the potential upside or downside of Swedish Orphan Biovitrum helps investors to forecast how Swedish stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Swedish Orphan more accurately as focusing exclusively on Swedish Orphan's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
265.37267.20269.03
Details

Swedish Orphan Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Swedish Orphan's current stock value. Our valuation model uses many indicators to compare Swedish Orphan value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Swedish Orphan competition to find correlations between indicators driving Swedish Orphan's intrinsic value. More Info.
Swedish Orphan Biovitrum is currently regarded as top stock in beta category among related companies. It is currently regarded as top stock in price to book category among related companies fabricating about  6.43  of Price To Book per Beta. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Swedish Orphan by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Swedish Orphan's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Swedish Orphan's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Swedish Orphan's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Swedish Orphan and how it compares across the competition.

About Swedish Orphan Valuation

The stock valuation mechanism determines the current worth of Swedish Orphan Biovitrum on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Swedish Orphan Biovitrum. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Swedish Orphan Biovitrum based exclusively on its fundamental and basic technical indicators. By analyzing Swedish Orphan's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Swedish Orphan's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Swedish Orphan. We calculate exposure to Swedish Orphan's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Swedish Orphan's related companies.
Swedish Orphan Biovitrum AB , an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, immunology, and genetic and metabolic diseases. Swedish Orphan Biovitrum AB is headquartered in Solna, Sweden. Swedish Orphan operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 1185 people.

8 Steps to conduct Swedish Orphan's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Swedish Orphan's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Swedish Orphan's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Swedish Orphan's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Swedish Orphan's revenue streams: Identify Swedish Orphan's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Swedish Orphan's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Swedish Orphan's growth potential: Evaluate Swedish Orphan's management, business model, and growth potential.
  • Determine Swedish Orphan's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Swedish Orphan's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Swedish Orphan Biovitrum. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Swedish Stock analysis

When running Swedish Orphan's price analysis, check to measure Swedish Orphan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Swedish Orphan is operating at the current time. Most of Swedish Orphan's value examination focuses on studying past and present price action to predict the probability of Swedish Orphan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Swedish Orphan's price. Additionally, you may evaluate how the addition of Swedish Orphan to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Please note, there is a significant difference between Swedish Orphan's value and its price as these two are different measures arrived at by different means. Investors typically determine if Swedish Orphan is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Swedish Orphan's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.